RA
OPCH icon

Royce & Associates’s Option Care Health OPCH Stock Holding History

Royce & Associates’s Portfolio OPCH Stock Details OPCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-226,138
Closed -$7.18M – 949
2023
Q1 		$7.18M Sell
226,138
-124,394
-35% -$3.73M 0.07% 401
2022
Q4 		$10.5M Buy
350,532
+5,500
+2% +$171K 0.11% 279
2022
Q3 		$10.9M Buy
345,032
+800
+0.2% +$25.6K 0.12% 246
2022
Q2 		$9.57M Sell
344,232
-39,400
-10% -$1.12M 0.1% 292
2022
Q1 		$11M Sell
383,632
-69,817
-15% -$1.75M 0.09% 327
2021
Q4 		$12.9M Sell
453,449
-266,200
-37% -$6.99M 0.1% 336
2021
Q3 		$17.5M Sell
719,649
-284,705
-28% -$6.6M 0.13% 239
2021
Q2 		$22M Sell
1,004,354
-179,500
-15% -$3.46M 0.15% 215
2021
Q1 		$21M Buy
1,183,854
+126,079
+12% +$2.36M 0.14% 234
2020
Q4 		$16.5M Buy
1,057,775
+187,000
+21% +$2.78M 0.14% 224
2020
Q3 		$11.6M Buy
870,775
+150,211
+21% +$1.83M 0.13% 242
2020
Q2 		$10M Sell
720,564
-1,500
-0.2% -$19.8K 0.11% 266
2020
Q1 		$6.84M Buy
722,064
+9,999
+1% +$147K 0.09% 290
2019
Q4 		$10.6M Buy
712,065
+67,762
+11% +$916K 0.09% 304
2019
Q3 		$8.25M Buy
644,303
+59,128
+10% +$728K 0.08% 357
2019
Q2 		$6.09M Buy
585,175
+55,550
+10% +$454K 0.06% 447
2019
Q1 		$4.24M Sell
529,625
-27,500
-5% -$362K 0.04% 543
2018
Q4 		$7.96M Buy
557,125
+6,125
+1% +$80.8K 0.07% 383
2018
Q3 		$6.83M Buy
551,000
+19,250
+4% +$225K 0.05% 502
2018
Q2 		$6.23M Buy
531,750
+33,000
+7% +$346K 0.04% 531
2018
Q1 		$4.91M Buy
498,750
+42,625
+9% +$493K 0.03% 576
2017
Q4 		$5.31M Buy
456,125
+412,375
+943% +$4.16M 0.04% 570
2017
Q3 		$481K Buy
+43,750
New +$494K ﹤0.01% 1025
2013
Q3 		– Sell
-1,000
Closed -$66K – 1473
2013
Q2 		$66K Buy
+1,000
New +$56.1K ﹤0.01% 1361

Other funds holding OPCH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $4.67B AUM 83.55% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Royce & Associates's OPCH Position: Q2 2023 in Review

Royce & Associates sold out of Option Care Health (OPCH) in Q2 2023, closing a stake of 226,138 shares — an estimated $7.18M sold.

Royce & Associates first reported a position in OPCH in Q2 2013 and held it in 24 quarters. The position peaked at $22M in Q2 2021. 314 funds tracked by Wall St. Rank hold OPCH as of Q2 2023.

  • Royce & Associates reported no remaining Option Care Health position as of Q2 2023 after selling out during the quarter.
  • Royce & Associates sold 226,138 Option Care Health shares in Q2 2023, an estimated $7.18M.
  • Royce & Associates first reported a position in Option Care Health in Q2 2013 and held it in 24 quarters.
  • Royce & Associates's Option Care Health position peaked at $22M in Q2 2021.
  • 314 funds tracked by Wall St. Rank held Option Care Health as of Q2 2023.

Based on Royce & Associates's 13F filing for Q2 2023, filed 7 Aug 2023.